KEVIN SPIKES: Open Payments
NPI 1083315659 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 38 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $373 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $151 |
| Novo Nordisk Inc | 9 | $142 |
| PFIZER INC. | 4 | $104 |
| Astellas Pharma US Inc | 3 | $85 |
| SHIELD THERAPEUTICS INC | 3 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Gilead Sciences, Inc. | 1 | $35 |
| Exact Sciences Corporation | 2 | $30 |
| Alkermes, Inc. | 1 | $24 |
Products named: QULIPTA, Veozah, NURTEC ODT, ACCRUFER, SPRAVATO, VRAYLAR, XIFAXAN, Wegovy.
Industry payments across GA — which companies pay providers there.
